"10.1371_journal.pctr.0020028","plos clinical trials","2007-06-15T00:00:00Z","Charles Kooperberg; Mary Cushman; Judith Hsia; Jennifer G Robinson; Aaron K Aragaki; John K Lynch; Alison E Baird; Karen C Johnson; Lewis H Kuller; Shirley A A Beresford; Beatriz Rodriguez","Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; College of Medicine, University of Vermont, Burlington, Vermont, United States of America; Department of Medicine, George Washington University, Washington, District of Columbia, United States of America; Department of Medicine, University of Iowa, Iowa City, Iowa, United States of America; Stroke Neuroscience Unit, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, United States of America; Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, United States of America; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America; Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington, United States of America; John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America","MC and AEB designed the study. CK, JGR, AKA, AEB, and LHK analyzed the data. JH, JGR, KCJ, and BR enrolled patients. All authors contributed to writing the paper. CK, MC, JH, JGR, JLK, KCJ, SAAB, and BR collected data or performed experiments for the study. SAAB oversaw the recruitment, data collection, and retention of women participating in the Seattle Clinical Center of the Womens Health Initiative. BR contributed patients from the Hawaii Center.","MC participated in three meetings as a consultant for Pharmacia, Novartis, and Merck on topics related to hormone therapies or selective estrogen receptor modulators in 2001 and 2003. JGR has received to date: Grants from Abbott, Andrx Labs, Astra-Zeneca, Atherogenics, Bristol-Myers Squibb, GlaxoSmithKline, Hoffman La Roche, Merck, Pfizer, Procter & Gamble, Sankyo, Schering-Plough, Takeda, and Wyeth Ayerst; Speaker honoraria for education programs from Bristol-Myers Squibb, Merck, and Pfizer; Honoraria from Reliant; Consultant/Advisory Board for Bristol -Myers Squibb, Merck, Pfizer, Proliant, Wellmark, and American Emu Association.","2007","06","Charles Kooperberg","CK",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
